Monday, 22 January 2018

Teva's asthma treatment fails late-stage studies

(Reuters) - Teva Pharmaceutical Industries said on Monday two late-stage studies testing its treatment for asthma did not meet their main goals.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)